Niflan; 2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid; pyranoprofen; Y-8004; 2-(5H-(1)Benzopyrano(2,3-b)pyridin-7-yl)propionic acid; CHEMBL367463; (2S)-2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid; 2-(5H-[1]Benzopyrano[2,3-b]pyridin-7-yl)propionic acid; NCGC00167980-01; 5H-(1)Benzopyrano(2,3,-b)pyridine-7-acetic acid, alpha-methyl-; DSSTox_CID_3497; DSSTox_RID_77055; DSSTox_GSID_23497; Pranoprofene; Pranoprofeno; Pranoprofenum; Pranoprofen [INN:JAN]; Pranoprofene [INN-French]; Pranoprofenum [INN-Latin]; Pranoprofeno [INN-Spanish]; SR-05000001513; 2-{5H-chromeno[2,3-b]pyridin-7-yl}propanoic acid; BRN 0889798; Pransus; Pranoprofen;; Elicapric (TN); 2-(5H-(1)Benzopyrano(2,3-b)pyridin-7yl)propionic acid; alpha-Methyl-5H-(1)-benzopyrano(2,3-b)pyridine-7-acetic acid; alpha-Methyl-5H-(1)benzopyrano(2,3-b)pyridine-7-acetic acid; Pranoprofen (JP17/INN); SCHEMBL26008; DTXSID1023497; CTK4J6071; Pranoprofen, >=98% (HPLC); AOB5667; 5H-[1]Benzopyrano[2,3-b]pyridine-7-aceticacid, a-methyl-; HMS2090J03; HMS3651G06; HMS3714I03; HMS3884O16; Pharmakon1600-01502324; BCP11947; EBD21357; HY-B0336; KS-00000XM9; Tox21_112601; 5H-[1]Benzopyrano[2,3-b]pyridine-7-acetic acid, .alpha.-methyl-; AC-697; BDBM50286819; MFCD00866111; NSC759832; s1960; AKOS015918442; Tox21_112601_1; CCG-213822; DB13514; NSC-759832; NCGC00167980-02; AK343797; AS-12631; SC-81252; AB0012256; FT-0652901; SW199147-2; D01578; J90002; AB01275517-01; AB01275517_02; AB01275517_03; 549P174; Q-201611; Q7238394; SR-05000001513-1; SR-05000001513-2; BRD-A64610707-001-01-0; i2-(10H-9-Oxa-1-aza-anthracen-6-yl)-propionic acid; 2-(5H-[1]benzopyrano-[2,3-b]pyridin-7-yl)propionic acid